Skip to main navigation Skip to search Skip to main content

Plasma bile acids more closely align with insulin resistance, visceral and hepatic adiposity than total adiposity

  • Ramy H. Bishay
  • , Katherine T. Tonks
  • , Jacob George
  • , Dorit Samocha-Bonet
  • , Gideon Meyerowitz-Katz
  • , David J. Chisholm
  • , David E. James
  • , Jerry R. Greenfield

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

Context: The etiological mechanism of bile acid (BA) effects on insulin resistance and obesity is unknown. Objective: This work aimed to determine whether plasma BAs are elevated in human obesity and/or insulin resistance. Methods: This observational study was conducted at an academic research center. Seventy-one adult volunteers formed 4 groups: lean insulin-sensitive (body mass index [BMI] ≤ 25 kg/m2, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR] < 2.0, n = 19), overweight/obese nondiabetic who were either insulin sensitive (Obsensitive, BMI > 25 kg/m2, HOMA-IR < 1.5, n = 11) or insulin resistant (Obresistant, BMI > 25 kg/m2, HOMA-IR > 3.0, n = 20), and type 2 diabetes (T2D, n = 21). Main outcome measures included insulin sensitivity by hyperinsulinemic-euglycemic clamp, body composition by dual energy x-ray absorptiometry, abdominal fat distribution, and liver density by computed tomography and plasma BA. Results: In the Obresistant group, glucose infusion rate/fat-free mass (GIR/FFM, an inverse measure of insulin resistance) was significantly lower, and visceral and liver fat higher, compared to lean and Obsensitive individuals, despite similar total adiposity in Obresistant and Obsensitive. Total BA concentrations were higher in Obresistant (2.62 ± 0.333 mmol/L, P = .03) and T2D (3.36 ± 0.582 mmol/L, P <. 001) vs Obsensitive (1.16 ± 0.143 mmol/L), but were similar between Obsensitive and lean (2.31 ± 0.329 mmol/L) individuals. Total BAs were positively associated with waist circumference (R = 0.245, P = .041), visceral fat (R = 0.360, P = .002), and fibroblast growth factor 21 (R = 0.341, P = .004) and negatively associated with insulin sensitivity (R = -0.395, P = .001), abdominal subcutaneous fat (R = -0.352, P = .003), adiponectin (R = -0.375, P = .001), and liver fat (Hounsfield units, an inverse marker of liver fat, R = -0.245, P = .04). Conjugated BAs were additionally elevated in T2D individuals (P < .001). Conclusions: BA concentrations correlated with abdominal, visceral, and liver fat in humans, though an etiological role in insulin resistance remains to be verified.

Original languageEnglish
Pages (from-to)e1131-e1139
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume106
Issue number3
DOIs
Publication statusPublished - 1 Mar 2021

Bibliographical note

Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • bile acids
  • fatty liver
  • insulin resistance
  • non, insulin, dependent diabetes
  • obesity

Fingerprint

Dive into the research topics of 'Plasma bile acids more closely align with insulin resistance, visceral and hepatic adiposity than total adiposity'. Together they form a unique fingerprint.

Cite this